Education
About Us
Working with TipRanks
Follow Us
Raffles Medical Group Ltd (RAFLF)
OTHER OTC:RAFLF
Total Valuation
Raffles Medical Group has a market cap or net worth of $1.54B. The enterprise value is $1.66B.
Market Cap$1.54B
Enterprise Value$1.66B
Share Statistics
Raffles Medical Group has 1,884,544,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,884,544,900
Owned by Insiders0.04%
Owned by Institutions0.04%
Financial Efficiency
Raffles Medical Group’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.89%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.89%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee256.04K
Profits Per Employee23.61K
Employee Count2,989
Asset Turnover0.54
Inventory Turnover55.81
Valuation Ratios
The current PE Ratio of Raffles Medical Group is ―. Raffles Medical Group’s PEG ratio is 1.95.
PE Ratio―
PS Ratio2.47
PB Ratio1.78
Price to Fair Value1.78
Price to FCF19.23
Price to Operating Cash Flow17.31
PEG Ratio1.95
Income Statement
In the last 12 months, Raffles Medical Group had revenue of 765.30M and earned 70.57M in profits. Earnings per share was 0.04.
Revenue765.30M
Gross Profit136.74M
Operating Income90.36M
Pretax Income94.26M
Net Income70.57M
EBITDA134.72M
Earnings Per Share (EPS)0.04
Cash Flow
In the last 12 months, operating cash flow was 108.29M and capital expenditures -10.44M, giving a free cash flow of 97.85M billion.
Operating Cash Flow108.29M
Free Cash Flow97.85M
Free Cash Flow per Share0.05
Dividends & Yields
Raffles Medical Group pays an annual dividend of $0.019, resulting in a dividend yield of 3.11%
Dividend Per Share$0.019
Dividend Yield3.11%
Payout Ratio73.41%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.09
52-Week Price Change11.66%
50-Day Moving Average0.77
200-Day Moving Average0.77
Relative Strength Index (RSI)79.56
Average Volume (3m)0.00
Important Dates
Raffles Medical Group upcoming earnings date is Aug 3, 2026, TBA (Confirmed).
Last Earnings DateFeb 22, 2026
Next Earnings DateAug 3, 2026
Ex-Dividend Date―
Financial Position
Raffles Medical Group as a current ratio of 1.31, with Debt / Equity ratio of 8.26%
Current Ratio1.31
Quick Ratio1.27
Debt to Market Cap0.05
Net Debt to EBITDA-1.45
Interest Coverage Ratio22.06
Taxes
In the past 12 months, Raffles Medical Group has paid 23.19M in taxes.
Income Tax23.19M
Effective Tax Rate0.25
Enterprise Valuation
Raffles Medical Group EV to EBITDA ratio is 12.55, with an EV/FCF ratio of 17.24.
EV to Sales2.21
EV to EBITDA12.55
EV to Free Cash Flow17.24
EV to Operating Cash Flow15.96
Balance Sheet
Raffles Medical Group has $334.18M in cash and marketable securities with $83.83M in debt, giving a net cash position of $250.35M billion.
Cash & Marketable Securities$334.18M
Total Debt$83.83M
Net Cash$250.35M
Net Cash Per Share$0.13
Tangible Book Value Per Share$0.56
Margins
Gross margin is 45.56%, with operating margin of 11.81%, and net profit margin of 9.22%.
Gross Margin45.56%
Operating Margin11.81%
Pretax Margin12.32%
Net Profit Margin9.22%
EBITDA Margin17.60%
EBIT Margin11.93%
Analyst Forecast
The average price target for Raffles Medical Group is $0.93, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$0.93
Price Target Upside16.25% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast―